文献速递细胞病理与分子病理

心包积液细胞病理学诊断价值:419例标本的临床病理分析

Diagnostic yield of cytopathology in evaluating pericardial effusions: Clinicopathologic analysis of 419 specimens.
PubMed 文献 · Cancer Cytopathol · 2016-10-24

该研究回顾性分析2008年1月至2014年9月419例心包积液细胞学标本(来自364例患者),并与同期心包活检结果比较。细胞学诊断阳性者62例(15%),可疑者25例(6%)。在排除可疑诊断后,细胞学与活检一致率为88.4%(153/173对),细胞学诊断恶性肿瘤的敏感性为92.1%,高于活检的55.3%。结论认为细胞学检查在心包积液评估中具有重要诊断价值,假阴性率低于活检,联合活检可提高检测敏感性。

要点

  • 心包积液细胞学诊断恶性肿瘤敏感性达92.1%,显著高于心包活检的55.3%。
  • 女性最常见原发肿瘤为乳腺癌和肺癌(各39.3%),男性为肺癌(47.4%)。
  • 细胞学与活检一致率为88.4%(153/173对),联合活检可提高敏感性。

核心结论

  • 细胞学检查在心包积液评估中具有显著诊断价值,假阴性率低于心包活检。
  • 同步送检心包活检与积液细胞学可提高恶性肿瘤检测敏感性,尤其适用于少量心包积液。

研究设计与样本

  • 回顾性分析2008年1月至2014年9月共419例心包积液细胞学标本,来自364例患者。
  • 将细胞学结果与同期进行的心包活检结果比较,对不一致病例进行复核以确定原因。

主要发现

  • 细胞学诊断分类:阴性332例(79%),可疑25例(6%),阳性62例(15%,来自51例患者)。
  • 阳性积液中47例患者已知患有恶性肿瘤。
  • 女性最常见原发肿瘤为乳腺癌(39.3%)和肺癌(39.3%),男性为肺癌(47.4%)。
  • 46%的患者同期进行了心包活检。
  • 排除可疑诊断后,细胞学与活检一致率为88.4%(153/173对)。

关键数值与推荐

  • 细胞学诊断恶性肿瘤的敏感性为92.1%,心包活检为55.3%。
  • 细胞学与活检一致率88.4%(153/173对配对样本)。

临床怎么用

  • 心包积液细胞学检查可作为评估恶性心包积液的有效手段。
  • 建议在送检积液细胞学的同时进行心包活检,以提高恶性肿瘤检出敏感性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pericardial effusions can cause considerable morbidity and potentially may lead to mortality. Malignant pericardial effusions are uncommon, and data on malignancies encountered in pericardial effusion cytology specimens are limited. METHODS: Relevant records of all pericardial effusions from January 2008 to September 2014 were examined and compared with pericardial biopsy results when performed. Discrepant cases were reviewed to determine the cause of the disagreement. RESULTS: In total, 419 pericardial effusion specimens obtained from 364 patients were examined. Cytologic diagnostic categories included: negative for malignancy (332 specimens; 79%), equivocal (25 specimens; 6%), and positive (62 specimens from 51 patients; 15%). Forty-seven patients who had positive effusions were known to have malignancy. The most common primary malignancies were breast (39.3%) and lung (39.3%) cancers in women and lung cancer (47.4%) in men. A concurrent pericardial biopsy was performed in 46% of patients. Excluding equivocal cytologic diagnoses, cytology and biopsy were concordant in 153 of 173 paired samples (88.4%). The sensitivity of cytology in diagnosing malignancy was 92.1% compared with 55.3% for pericardial biopsy. CONCLUSIONS: Cytologic examination has significant diagnostic utility in the evaluation of pericardial effusions and exhibits a lower false-negative rate compared with pericardial biopsy. Submission of pericardial biopsy alongside effusion cytology is associated with increased sensitivity for detecting malignancy and may be especially useful in the setting of low-volume pericardial effusion. Cancer Cytopathol 2017;125:128-137. © 2016 American Cancer Society.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Saab J, Hoda RS, Narula N, et al. Diagnostic yield of cytopathology in evaluating pericardial effusions: Clinicopathologic analysis of 419 specimens. Cancer Cytopathol. 2016. PMID: 28207201. doi:10.1002/cncy.21790

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。